新生儿与婴儿Ross手术的长期结局:多机构分析
该国际多机构回顾性研究纳入1996至2016年间6个中心接受Ross手术的133例婴儿(其中新生儿30例),随访至少5年。结果显示出院后生存良好,自体移植物再干预与主动脉瓣反流长期控制理想,新主动脉扩张在长期随访中恢复正常。
要点
- 院内死亡13/133(10%),其中新生儿4/30(13%)。
- 出院后死亡10/120(8%),Ross术后中位298天。
- 15年免于中度及以上新主动脉反流为86%。
核心结论
- 新生儿和婴儿Ross术后出院后生存良好,长期免于自体移植物再干预和主动脉瓣反流,新主动脉扩张在长期随访中恢复正常。
研究设计与样本
- 国际多机构Ross协作组纳入6个三级中心,回顾性识别1996至2016年间接受Ross手术且随访至少5年的婴儿,共133例(新生儿30例),并分析连续超声心动图评估新主动脉尺寸与功能变化。
主要发现
- 133例中院内死亡13例(10%),新生儿为4/30(13%);出院后120例中死亡10例(8%),中位时间为Ross术后298天。
- Ross术后出现新主动脉扩张,于2至3年时达正常值以上4至5个标准差峰值,后在中位随访11.5(6.4-17.4)年时回落至接近基线z评分。
- 120例中5例(4%)需自体移植物/左心室流出道再干预,中位时间10.3(4.1-12.8)年;15年免于中度及以上新主动脉反流为86%。
关键数值与推荐
- 主要诊断包括孤立性主动脉瓣狭窄19例(14%)、Shone复合征19例(14%)、主动脉瓣狭窄合并其他(除外Shone复合征)95例(71%),其中含弓部梗阻55例、左心室发育不良9例、二尖瓣病变(中度及以上狭窄或反流)31例。
- Ross手术时中位年龄96天(四分位距36-186),中位体重4.4 kg(3.6-6.5)。
临床怎么用
- 结果支持在新生儿和婴儿主动脉瓣疾病中增加对Ross手术的考虑。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: For neonates and infants with aortic valve pathology, the Ross procedure historically has been associated with high rates of morbidity and mortality. Data regarding long-term durability are lacking. METHODS: The international, multi-institutional Ross Collaborative included 6 tertiary care centers. Infants who underwent a Ross operation between 1996 and 2016 (allowing a minimum 5 years of follow-up) were retrospectively identified. Serial echocardiograms were examined to study evolution in neoaortic size and function. RESULTS: Primary diagnoses for the 133 patients (n = 30 neonates) included isolated aortic stenosis (14%, n = 19), Shone complex (14%, n = 19), and aortic stenosis plus other (excluding Shone complex; n = 95, 71%), including arch obstruction (n = 55), left ventricular hypoplasia (n = 9), and mitral disease (moderate or greater stenosis or regurgitation, n = 31). At the time of the Ross procedure, median age was 96 days (interquartile range, 36-186), and median weight was 4.4 kg (3.6-6.5). In-hospital mortality occurred in 13 of 133 patients (10%) (4/30 [13%] neonates). Postdischarge mortality occurred in 10 of 120 patients (8%) at a median of 298 days post-Ross. Post-Ross neoaortic dilatation occurred, peaking at 4 to 5 SDs above normal at 2 to 3 years before returning to near-baseline z-score at a median follow-up of 11.5 [6.4-17.4] years. Autograft/left ventricular outflow tract reintervention was required in 5 of 120 patients (4%) at a median of 10.3 [4.1-12.8] years. Freedom from moderate or greater neoaortic regurgitation was 86% at 15 years. CONCLUSIONS: Neonates and infants experience excellent postdischarge survival and long-term freedom from autograft reintervention and aortic regurgitation after the Ross. Neoaortic dilatation normalizes in this population in the long-term. Increased consideration should be given to Ross in neonates and infants with aortic valve disease.
引用
- Greenberg JW, Argo M, Ashfaq A, et al. Long-term outcomes following the Ross procedure in neonates and infants: A multi-institutional analysis. J Thorac Cardiovasc Surg. 2024. PMID: 38971401. doi:10.1016/j.jtcvs.2024.06.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。